Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
ORCX: A Leveraged ETF for Short-Term Exposure to Oracle

ORCX: A Leveraged ETF for Short-Term Exposure to Oracle

Key Takeaways

  • ORCX is a leveraged single-stock exchange-traded fund (ETF) that seeks daily investment results equal to two times (200%) the daily percentage change in the share price of Oracle Corporation (ORCL).
  • The fund is issued by Defiance ETFs and is actively managed, using derivatives such as swap agreements and options to achieve its leveraged exposure.
  • ORCX launched in February 2025 and is listed on the Nasdaq Stock Market.
  • Because it is designed to reset its leverage daily, ORCX is intended for short-term, experienced traders rather than long-term buy-and-hold investors.
  • The fund carries a notably high net expense ratio and is non-diversified, concentrating risk in a single underlying company.

Introduction

ORCX represents the Defiance Daily Target 2X Long ORCL ETF, a specialized leveraged product designed to deliver twice the daily performance of Oracle Corporation. This ETF falls into the category of single-stock leveraged funds, which allow investors to gain amplified exposure to one underlying security through an exchange-traded vehicle. In my view, many traders follow ORCX as a tactical instrument for expressing a short-term bullish stance on Oracle, a major player in enterprise software and cloud infrastructure.

ETF Overview and Investment Strategy

The primary goal of the fund is to achieve, before fees and expenses, daily results that correspond to 200% of Oracle’s daily price change. This objective relies on an actively managed approach rather than passive index tracking. To deliver the leverage, the strategy incorporates derivatives such as swap agreements and listed options. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Defiance ETFs serves as the issuer, operating under the Tidal Trust II structure. The ETF began trading on February 6, 2025, on the Nasdaq Stock Market. Its non-diversified nature means performance ties closely to Oracle alone, which introduces concentrated exposure by design.

Portfolio Holdings and Allocation

Although returns track Oracle’s daily moves, the actual holdings consist mainly of cash equivalents and derivatives rather than direct stock ownership. Typical positions include U.S. Treasury bills, money-market instruments like the First American Government Obligations Fund, and Oracle-linked swaps. This setup supports the 2x daily target with a relatively compact portfolio.

Costs reflect the complexities of leveraged management. The gross expense ratio stands at approximately 1.36%, while the net expense ratio comes in around 1.29%.

Why Investors Follow ORCX

Traders often turn to ORCX for concentrated, amplified exposure to Oracle without needing to manage margin or options directly. Oracle continues to attract attention due to its cloud infrastructure growth and artificial intelligence initiatives, such as data center expansions and enterprise AI applications. For those seeking short-term directional exposure to these themes, the ETF provides a single-vehicle option that aims for roughly double the daily movement of the underlying stock.

One thing that stands out is its explicit short-term orientation. The daily reset mechanism means longer holding periods can produce results that differ meaningfully from twice the cumulative return of Oracle.

Risks and Important Considerations

The leveraged, daily-reset design represents the most notable risk. Leverage amplifies both gains and losses, and the reset feature can lead to substantial divergence from 2x the underlying return over multiple days. Volatility decay often plays a role here, particularly in sideways or volatile markets, and can reduce value even if Oracle trends higher over time.

Concentration in one company also means investors face Oracle-specific risks, including competition in cloud and software markets, changes in technology spending, and macroeconomic factors that influence tech valuations. The higher expense ratio and derivative usage add layers of counterparty and operational considerations. From what I see, this product suits only sophisticated, short-term traders who monitor positions actively.

Using AI Tools in Analysis

In my research process, I frequently rely on Tickeron’s AI-powered platforms to scan for patterns and compare opportunities across sectors. These tools help surface ideas that align with specific strategies without replacing individual due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCX

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for ORCX turns negative, indicating new downward trend

ORCX saw its Momentum Indicator move below the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator turned negative. In 20 of the 22 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ORCX turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In 14 of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ORCX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +8.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCX advanced for three days, in 86 of 92 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

ORCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Oracle Corporation (NYSE: ORCL). The fund is an actively managed exchange traded fund (“ETF”) that attempts to achieve two times (200%) the daily percentage change in the share price of the underlying security by employing derivatives, namely swap agreements and/or listed options contracts. The fund is non-diversified.
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.